Comstock Inc. (LODE)
Comstock Inc. (LODE)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | NaN | 374,356 | 1,179,440 | NaN |
| Mining Segment | NaN | 0 | 0 | NaN |
| Strategic Investments Segment | NaN | 0 | 0 | NaN |
| Corporate And Other | NaN | 0 | 0 | NaN |
| All Segments Except Bioleum | NaN | 601,768 | 2,025,194 | NaN |
| Bioleum Segment | NaN | 0 | 0 | NaN |
| Cost of goods sold | NaN | 601,768 | 2,025,194 | NaN |
| Cost of goods sold | NaN | 601,768 | 2,025,194 | NaN |
| Selling and marketing | NaN | 306,030 | 747,399 | NaN |
| General and administrative | NaN | 6,361,420 | 13,256,167 | NaN |
| Research and development | NaN | 4,665,503 | 7,654,401 | NaN |
| Depreciation and amortization | NaN | 1,667,904 | 2,174,322 | NaN |
| Metals Segment | NaN | 0 | 0 | NaN |
| Mining Segment | NaN | 0 | 0 | NaN |
| Strategic Investments Segment | NaN | 0 | 0 | NaN |
| Corporate And Other | NaN | 0 | 9,333 | NaN |
| All Segments Except Bioleum | NaN | 0 | 9,333 | NaN |
| Bioleum Segment | NaN | 0 | 0 | NaN |
| Impairment of intangible assets | NaN | 0 | 9,333 | NaN |
| Impairment of properties, plant and equipment | NaN | 0 | 433,411 | NaN |
| Metals Segment | NaN | 0 | 0 | NaN |
| Mining Segment | NaN | 0 | 200,000 | NaN |
| Strategic Investments Segment | NaN | 0 | 0 | NaN |
| Corporate And Other | NaN | 0 | 0 | NaN |
| All Segments Except Bioleum | NaN | 0 | 200,000 | NaN |
| Bioleum Segment | NaN | 0 | 0 | NaN |
| (gain) on sale of mineral rights | NaN | 0 | 200,000 | NaN |
| Loss from operations | NaN | -13,228,269 | -24,920,787 | NaN |
| Metals Segment | NaN | 7 | 1,390 | NaN |
| Mining Segment | NaN | 61,490 | -1,967,441 | NaN |
| Strategic Investments Segment | NaN | -375,000 | 400,170 | NaN |
| Corporate And Other | NaN | 1,251,414 | -4,951,106 | NaN |
| All Segments Except Bioleum | NaN | 937,911 | -6,516,987 | NaN |
| Bioleum Segment | NaN | -1,067,318 | 1,628,564 | NaN |
| Total other income (expense), net | NaN | -129,407 | -4,888,423 | NaN |
| Net loss | -9,383,417 | -13,357,676 | -12,888,336 | -16,920,874 |
| Depreciation and amortization | 1,378,574 | 1,651,228 | 1,147,259 | 992,498 |
| Impairment of properties, plant and equipment (note 6) | NaN | 0 | 433,411 | NaN |
| Loss on extinguishment of debt | NaN | 0 | -2,767,887 | 0 |
| Goodwill and intangible asset impairment | NaN | 0 | 9,333 | NaN |
| Amortization of finance leases | 12,937 | 25,620 | NaN | 25,621 |
| Accretion of interest | 147,273 | 455,262 | 38,431 | 0 |
| Amortization of debt discount and other debt-related items | 0 | 0 | 56,617 | 485,853 |
| Accretion of reclamation liability | 120,269 | 117,560 | 114,935 | 222,302 |
| Gain on sale of mineral rights (note 6) | NaN | 0 | 200,000 | NaN |
| Loss on investments (note 4) | NaN | 0 | NaN | NaN |
| Interest expense paid with common stock | 0 | 0 | 116,997 | 284,526 |
| Research and development expense paid with common stock | NaN | NaN | NaN | 1,487,476 |
| Change in fair value of safe note | NaN | NaN | 900,000 | NaN |
| Research and development expense paid with common stock | 0 | 0 | 1,487,476 | NaN |
| Gain on write-off of ssof deposits | NaN | NaN | 0 | 0 |
| Research and development expense recognized on renfuel ip and genmat transactions (notes 4 and 5) | NaN | 3,052,869 | NaN | NaN |
| Gain on extinguishment of liability | 0 | 0 | 0 | 845,000 |
| Loss on conversion of debt | 0 | 0 | 242,664 | -3,330,831 |
| Director share-based compensation | 321,659 | NaN | 0 | 0 |
| Flux photon payable | NaN | 836,004 | -2,332,990 | 973,634 |
| Change in fair value of derivative instruments | -722,015 | 1,009,976 | -1,243,382 | 1,677,373 |
| (gain) loss on expiration of linico and ssof deposits | NaN | -375,000 | NaN | NaN |
| Share of net (income) loss of equity-method investments | -251,844 | -24,000 | -24,000 | 17,438 |
| Other | 12,079 | 431,275 | -229,001 | -336,926 |
| Accounts receivable | -976,365 | -420,335 | 373,568 | -1,502,064 |
| Prepaid expenses and other current assets | NaN | 56,366 | NaN | NaN |
| Prepaid expenses | 229,794 | NaN | 198,113 | -65,099 |
| Deposits | 0 | 19,697 | 157,500 | 217,500 |
| Other assets | -210,141 | -694,090 | -493,605 | 454,973 |
| Deferred revenue | NaN | NaN | NaN | 983,333 |
| Accounts payable-Excluding Flux Photon | 1,017,380 | NaN | NaN | NaN |
| Accrued expenses and other liabilities | -963,786 | 197,834 | 6,906 | -247,712 |
| Deferred revenue-Metals Recycling | 250,917 | 260,801 | 1,687,111 | NaN |
| Deferred revenue - metal recycling-Income Grant | NaN | 0 | 1,000,000 | NaN |
| Accounts payable-Flux Photon | -480,000 | -1,000,000 | NaN | NaN |
| Other liabilities | -30,442 | 805,472 | 225,682 | -88,478 |
| Net cash used in operating activities | -5,823,158 | -5,900,280 | -8,707,568 | -9,779,185 |
| Deposits paid on equipment-Comstock Metals | 2,024,149 | 7,571,679 | NaN | NaN |
| Purchase of mineral rights and properties, plant and equipment | 5,676,932 | 707,363 | 920,617 | 709,572 |
| Investment in sierra springs opportunity fund-Sierra Springs Opportunity Fund Inc SSOF | NaN | NaN | 650,000 | NaN |
| Advances to ssof-Sierra Springs Opportunity Fund Inc SSOF | NaN | 6,900,000 | 2,500,000 | NaN |
| Deposits paid on equipment | NaN | NaN | 5,140,028 | NaN |
| Proceeds from sale of mineral rights (note 6) | NaN | 0 | 1,950,000 | NaN |
| Acquisition of intangible asset | 0 | 0 | 0 | 300,000 |
| Cash paid for acquisition of hexas, net-Hexas | NaN | 416,471 | NaN | NaN |
| Payments to acquire note-Renfuel Note Receivable | 0 | 200,000 | NaN | 800,000 |
| Funding of renfuel note receivable | NaN | NaN | 1,000,000 | NaN |
| Payments to acquire note-Hexas Safe | 0 | 1,135,000 | NaN | NaN |
| Advances to ssof-Genmat | NaN | 0 | 0 | 0 |
| Advances in ssof-Sierra Springs Opportunity Fund Inc SSOF | 5,750,000 | NaN | NaN | NaN |
| Investment in hexas safe note | NaN | NaN | 194,666 | 765,334 |
| Investment in ssof-Sierra Springs Opportunity Fund Inc SSOF | 2,000,000 | 0 | NaN | 650,000 |
| Payments on contractual commitments associated with derivatives | 129,000 | 129,000 | 86,000 | 230,000 |
| Proceeds received from contractual commitments associated with derivatives | 1,231,667 | NaN | NaN | NaN |
| Funding of reclamation bond | NaN | 600,000 | NaN | NaN |
| Payment of reclamation bond deposit | -300,000 | NaN | 150,000 | 300,000 |
| Other | 34,122 | -30,516 | 36,850 | 63,788 |
| Debt issuance costs | NaN | 0 | 0 | NaN |
| Net cash used in investing activities | -14,532,536 | -10,878,969 | -7,278,161 | -3,818,694 |
| Issuance of equity in subsidiary - bioleum corporation | NaN | 0 | 0 | 20,000,000 |
| Proceeds from the issuance of common stock | 60,979,181 | 2,221,512 | 34,500,002 | 1,500,000 |
| Issuances of debt | 0 | 0 | 0 | 10,000,000 |
| Principal payments of debt | 0 | 0 | 2,500,000 | 100,000 |
| Common stock issuance costs | 4,606,575 | 202,970 | 2,889,663 | 145,000 |
| Principal payments on financing leases | 756 | 0 | 0 | 23,650 |
| Net cash provided by financing activities | 56,371,850 | 2,018,542 | 29,110,339 | 31,231,350 |
| Net increase (decrease) in cash and cash equivalents | 36,016,156 | -14,760,707 | 13,124,610 | 17,633,471 |
| Cash and cash equivalents at beginning of period | 16,951,645 | 31,712,352 | 954,271 | NaN |
| Cash and cash equivalents at end of period | 52,967,801 | 16,951,645 | 31,712,352 | NaN |